Healthtech
Q3 202418.07.2024

Drug discovery (Q3 2024)

Picture of Kai Nicol-Schwarz

Kai Nicol-Schwarz

at Sifted

Developing drugs is a very long and expensive process. It can take between 10 and 15 years and cost more than $1bn to bring one to market. It’s also hit and miss — with the latter doing most of the heavy lifting. 90% of drugs that make it to human trials — the final stage before approval — fail.

But increasingly startups are looking to speed up the process using new tech like proprietary machine learning algorithms and generative AI. While some are looking to develop their own drug candidates, others are building tools to be used by pharma companies and other biotechs.

For startups, there are reasons to be cheerful. AI and ML present a “huge opportunity” for tech companies to solve problems in the drug discovery space, one investor tells Sifted. Another says the approaching “patent cliff” — which will see several revenue-driving drug patents expire — is an “unprecedented opportunity” for startups as pharma companies look to bolster drug pipelines. Others say they’ve noticed lead times to sell into pharma drop since pre-Covid times.

Positive moves — but it’s still early days. While there are some AI-developed drugs in clinical trials, none have yet made it to market. With or without startups — drug discovery is a long game. Investors say major AI-driven advances in the drug discovery process will likely come in the next decade, rather than the next few years. But, if VC confidence in the sector holds, there’s every chance startups could play an increasingly key role in the sector going forward.

20 startups to watch

  • CHARM Therapeutics logo

    Sifted score

    9.13
    -

    CHARM Therapeutics

    3D deep learning for undruggable diseases.

    • Strong investor(s)
    • Serial founder(s)
    • Year founded

      2021

    • HQ

      London, United Kingdom

    • Latest round

      Early VC
      18.2m / Apr 2023

    • Total funding

      75.1m

  • Aqemia logo

    Sifted score

    9.02
    -

    Aqemia

    • Strong investor(s)
    • Serial founder(s)
    • Hiring
    • Year founded

      2019

    • HQ

      Paris, France

    • Latest round

      Series A
      30m / Jan 2024

    • Total funding

      70.9m

  • Chemify logo

    Sifted score

    8.08
    -

    Chemify

    • Strong investor(s)
    • Serial founder(s)
    • Hiring
    • Year founded

      2022

    • HQ

      Glasgow, United-Kingdom

    • Latest round

      Series A
      39.8m / Aug 2023

    • Total funding

      39.8m

  • Abzu logo

    Sifted score

    7.98
    -

    Abzu

    Explainable AI for pharmaceutical research.

    • Strong investor(s)
    • Serial founder(s)
    • Year founded

      2018

    • HQ

      Copenhagen, Denmark

    • Latest round

      Grant
      2.5m / Jun 2022

    • Total funding

      10.4m

  • Kvantify logo

    Sifted score

    7.97
    -

    Kvantify

    • Strong investor(s)
    • Serial founder(s)
    • Year founded

      2022

    • HQ

      Copenhagen, Denmark

    • Latest round

      Grant
      2m / Oct 2023

    • Total funding

      9m

Related Briefings

Related articles

‘How do I want my daughter to grow up?’: Clue CEO Audrey Tsang steps down from role
Startup LifeInterview

October 7, 2024

‘How do I want my daughter to grow up?’: Clue CEO Audrey Tsang steps down from role

By Miriam Partington
11 Cambridge startups to watch, according to investors

October 7, 2024

11 Cambridge startups to watch, according to investors

Startups in Cambridge have raised the most funding of any city in the UK other than London so far this year

By Kai Nicol-Schwarz
Pro
How to raise from high-net-worth individuals

October 7, 2024

How to raise from high-net-worth individuals

By Anisah Osman Britton
Sam Altman’s Worldcoin deprioritises Europe amid GDPR regulatory fight

October 7, 2024

Sam Altman’s Worldcoin deprioritises Europe amid GDPR regulatory fight

By Tom Matsuda
Graphcore — bought by SoftBank for $600m+ — made $4m in revenue in 2023

October 4, 2024

Graphcore — bought by SoftBank for $600m+ — made $4m in revenue in 2023

By Kai Nicol-Schwarz
Flying taxi startup Lilium faces insolvency if not able to "immediately" raise more capital 

October 4, 2024

Flying taxi startup Lilium faces insolvency if not able to "immediately" raise more capital 

Lilium 7-seater jettt
By Mimi Billing
The things nobody told me about launching a VC firm: How to set up a fund structure

October 4, 2024

The things nobody told me about launching a VC firm: How to set up a fund structure

By Carmen Alfonso Rico
“You don’t need to burnout in order to succeed”: Key learnings on scaling a European startup at Sifted Summit
Startup LifeAnalysis

October 4, 2024

“You don’t need to burnout in order to succeed”: Key learnings on scaling a European startup at Sifted Summit

Fabio Bin, cofounder and CMO of WeRoad; Corinne Aaron, CMO at Einride; Marni Allen, CMO at Bioniq; Anisah Osman Britten, Sifted's Startup Life reporter on stage at Sifted Summit
By Miriam Partington
12 fastest-growing CEE startup teams
Startup LifeAnalysis

October 4, 2024

12 fastest-growing CEE startup teams

From nano-satellites to autonomous robotaxis, these are the startups whose teams grew the most in the last 12 months

By Zosia Wanat
Pro
'It’s not hard to wire a lot of money to Nvidia': Aleph Alpha’s Jonas Andrulis on the difficulty of making an LLM business work
DeeptechAnalysis

October 3, 2024

'It’s not hard to wire a lot of money to Nvidia': Aleph Alpha’s Jonas Andrulis on the difficulty of making an LLM business work

By Tim Smith
'We have to build a very strong revenue engine': Poolside AI gets ready to release product after a year of secrecy
DeeptechInterview

October 3, 2024

'We have to build a very strong revenue engine': Poolside AI gets ready to release product after a year of secrecy

By Daphné Leprince-Ringuet
“I still think it is the best time ever to be a founder in Europe": Takeaways from Sited Summit's Day One
Startup LifeAnalysis

October 3, 2024

“I still think it is the best time ever to be a founder in Europe": Takeaways from Sited Summit's Day One

By Daphné Leprince-Ringuet
Is European fintech over its hump?
FintechAnalysis

October 3, 2024

Is European fintech over its hump?

By Sadia Nowshin
Eurazeo’s Kurma Partners hits first close of €140m for biotech fund

October 3, 2024

Eurazeo’s Kurma Partners hits first close of €140m for biotech fund

By Kai Nicol-Schwarz
‘A constant stream of complicated things:’ Germany-based founders battle bureaucracy
Startup LifeAnalysis

October 3, 2024

‘A constant stream of complicated things:’ Germany-based founders battle bureaucracy

By Miriam Partington
German autonomous trucking startup Fernride is eyeing defence applications, says cofounder
DeeptechInterview

October 3, 2024

German autonomous trucking startup Fernride is eyeing defence applications, says cofounder

Image of a Fernride truck
By Anne Sraders
5 neurotech & mental health startups raising funds

October 3, 2024

5 neurotech & mental health startups raising funds

Sifted scouted and contacted 78 European early-stage neurotech & mental health startups to discover which are actively fundraising

By Ruggero Di Spigna
Pro
AI startup Poolside raises $500m Series B

October 2, 2024

AI startup Poolside raises $500m Series B

Bain Capital Ventures led the round and was joined by the likes of DST Global and Nvidia

By Daphné Leprince-Ringuet
“I wouldn’t be a CEO founder again”: Anne Boden at the Sifted Summit
Startup LifeInterview

October 2, 2024

“I wouldn’t be a CEO founder again”: Anne Boden at the Sifted Summit

Anne Boden speaking to Amy Lewin on stage at the Sifted Summit 2024
By Amy Lewin
Majority of Northvolt’s government funding has never hit its bank account
Climate TechAnalysis

October 2, 2024

Majority of Northvolt’s government funding has never hit its bank account

By Freya Pratty and Mimi Billing
Pro
Can Germany become a deeptech capital of Europe?
DeeptechAnalysis

October 2, 2024

Can Germany become a deeptech capital of Europe?

By Anne Sraders
From one of Europe’s fastest-growing startups to sustainable growth: how Kilo Health wants to reach €1bn revenue
HealthtechInterview

October 2, 2024

From one of Europe’s fastest-growing startups to sustainable growth: how Kilo Health wants to reach €1bn revenue

Tadas Burgaila, Kilo Health cofounder
By Zosia Wanat
Investors show mixed feelings about Austria’s far-right electoral win

October 1, 2024

Investors show mixed feelings about Austria’s far-right electoral win

Vienna, Austria
By Zosia Wanat and Miriam Partington
UK fintechs scramble ahead of new fraud compensation scheme
FintechAnalysis

October 1, 2024

UK fintechs scramble ahead of new fraud compensation scheme

Nicky Goulimis, Co-Founder, Nova Credit
By Tom Matsuda